Introduction to The Development Of Clinical Guidelines For Older Patients With Aml
Exploring The Development Of Clinical Guidelines For Older Patients With Aml reveals several interesting facts. In this video, Pinkal Desai, MD, MPH, Weill Cornell
The Development Of Clinical Guidelines For Older Patients With Aml Comprehensive Overview
During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the Dr. Mikkael Sekeres, Chair of the ASH Learn more about
Jorge E. Cortes, MD, discusses the data from a recent trial looking at low-dose cytarabine +/- glasdegib for
Summary & Highlights for The Development Of Clinical Guidelines For Older Patients With Aml
- The ASH Clinical
- Wolfgang Hiddemann, MD, PhD, from Ludwig-Maximilians University, Munich, Germany, provides us an insight into the difficulties ...
- During the 1st NCRI
- For a long while, the only
- Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY, discusses ongoing
Stay tuned for more updates related to The Development Of Clinical Guidelines For Older Patients With Aml.
